{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:58:02Z","timestamp":1792173482813,"version":"4.4.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular Graphics and Modelling"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.jmgm.2022.108280","type":"journal-article","created":{"date-parts":[[2022,8,8]],"date-time":"2022-08-08T05:33:58Z","timestamp":1659936838000},"page":"108280","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Functionalized carbon nanotubes as an alternative to traditional anti-HIV-1 protease inhibitors: An understanding towards Nano-medicine development through MD simulations"],"prefix":"10.1016","volume":"117","author":[{"given":"Madhusmita","family":"Panda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7815-3312","authenticated-orcid":false,"given":"Priyanka","family":"Purohit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biswa Ranjan","family":"Meher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jmgm.2022.108280_bib1","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.3390\/v1031110","article-title":"HIV-1 protease: structural perspectives on drug resistance","volume":"1","author":"Weber","year":"2009","journal-title":"Viruses"},{"key":"10.1016\/j.jmgm.2022.108280_bib2","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1110\/ps.0206702","article-title":"Drug resistance in HIV-1 protease: flexibility-assisted mechanism of compensatory mutations","volume":"11","author":"Piana","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2022.108280_bib3","series-title":"Mutation Effects on 3D-Structural Reorganization Using HIV-1 Protease as a Case Study","author":"Meher","year":"2019"},{"key":"10.1016\/j.jmgm.2022.108280_bib4","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/B978-0-12-411636-8.00008-0","article-title":"Structural and dynamical aspects of HIV-1 protease and its role in drug resistance","volume":"92","author":"Meher","year":"2013","journal-title":"Adv. Protein Chem. Struct. Biol."},{"key":"10.1016\/j.jmgm.2022.108280_bib5","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1021\/jm970689r","article-title":"Optimizing the binding of fullerene inhibitors of the HIV-1 protease through predicted increases in hydrophobic desolvation","volume":"41","author":"Friedman","year":"1998","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2022.108280_bib6","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jconrel.2020.08.001","article-title":"Anticancer DOX delivery system based on CNTs: functionalization, targeting and novel technologies","volume":"327","author":"Yaghoubi","year":"2020","journal-title":"J. Contr. Release"},{"key":"10.1016\/j.jmgm.2022.108280_bib7","series-title":"Smart Nanoparticles for Biomedicine","first-page":"103","article-title":"Carbon nanomaterials for nanomedicine","author":"d'Amora","year":"2018"},{"key":"10.1016\/j.jmgm.2022.108280_bib8","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.cbpa.2005.10.005","article-title":"Applications of carbon nanotubes in drug delivery","volume":"9","author":"Bianco","year":"2005","journal-title":"Curr. Opin. Chem. Biol."},{"key":"10.1016\/j.jmgm.2022.108280_bib9","doi-asserted-by":"crossref","first-page":"6506","DOI":"10.1021\/ja00068a005","article-title":"Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verification","volume":"115","author":"Friedman","year":"1993","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2022.108280_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmgm.2022.108145","article-title":"Molecular modelling and dynamics simulations of single-wall carbon nanotube as a drug carrier: new insights into the drug-loading process","volume":"113","author":"von Ranke","year":"2022","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2022.108280_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.compbiomed.2021.104692","article-title":"Tracking the interaction between single-wall carbon nanotube and SARS-Cov-2 spike glycoprotein: a molecular dynamics simulations study","volume":"136","author":"Jomhori","year":"2021","journal-title":"Comput. Biol. Med."},{"key":"10.1016\/j.jmgm.2022.108280_bib12","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1477-3155-11-30","article-title":"Carbon nanotubes as a novel tool for vaccination against infectious diseases and cancer","volume":"11","author":"Gottardi","year":"2013","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jmgm.2022.108280_bib13","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12951-016-0196-7","article-title":"Multi-walled carbon nanotubes increase antibody-producing B cells in mice immunized with a tetravalent vaccine candidate for dengue virus","volume":"14","author":"Calegari","year":"2016","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jmgm.2022.108280_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s10867-016-9440-5","article-title":"Molecular dynamics exploration of the binding mechanism and properties of single-walled carbon nanotube to WT and mutant VP35 FBP region of Ebola virus","volume":"43","author":"Zhang","year":"2017","journal-title":"J. Biol. Phys."},{"key":"10.1016\/j.jmgm.2022.108280_bib15","doi-asserted-by":"crossref","first-page":"9957","DOI":"10.1016\/j.bmc.2008.10.039","article-title":"Computational design of novel fullerene analogues as potential HIV-1 PR inhibitors: analysis of the binding interactions between fullerene inhibitors and HIV-1 PR residues using 3D QSAR, molecular docking and molecular dynamics simulations","volume":"16","author":"Durdagi","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.jmgm.2022.108280_bib16","doi-asserted-by":"crossref","first-page":"6283","DOI":"10.1016\/j.bmcl.2008.09.107","article-title":"3D QSAR CoMFA\/CoMSIA, molecular docking and molecular dynamics studies of fullerene-based HIV-1 PR inhibitors","volume":"18","author":"Durdagi","year":"2008","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.jmgm.2022.108280_bib17","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2174\/157018010792062759","article-title":"The quantitative structure activity relationships for predicting HIV protease inhibition by substituted fullerenes","volume":"7","author":"Martin","year":"2010","journal-title":"Lett. Drug Des. Discov."},{"key":"10.1016\/j.jmgm.2022.108280_bib18","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10822-011-9475-4","article-title":"Binding of novel fullerene inhibitors to HIV-1 protease: insight through molecular dynamics and molecular mechanics Poisson-Boltzmann surface area calculations","volume":"25","author":"Tzoupis","year":"2011","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.jmgm.2022.108280_bib19","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/psc.2828","article-title":"Fullerene-based inhibitors of HIV-1 protease","volume":"21","author":"Strom","year":"2015","journal-title":"J. Pept. Sci."},{"key":"10.1016\/j.jmgm.2022.108280_bib20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1021\/bi020496s","article-title":"Molecular dynamics study of the connection between flap closing and binding of fullerene-based inhibitors of the HIV-1 protease","volume":"42","author":"Zhu","year":"2003","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2022.108280_bib21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jmgm.2010.05.009","article-title":"Structure-based design of carbon nanotubes as HIV-1 protease inhibitors: atomistic and coarse-grained simulations","volume":"29","author":"Cheng","year":"2010","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2022.108280_bib22","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jmgm.2012.10.001","article-title":"Binding of single walled carbon nanotube to WT and mutant HIV-1 proteases: analysis of flap dynamics and binding mechanism","volume":"38","author":"Meher","year":"2012","journal-title":"J. Mol. Graph. Model."},{"key":"10.1016\/j.jmgm.2022.108280_bib23","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/chem.200305534","article-title":"Overcoming the insolubility of carbon nanotubes through high degrees of sidewall functionalization","volume":"10","author":"Dyke","year":"2004","journal-title":"Chemistry"},{"key":"10.1016\/j.jmgm.2022.108280_bib24","article-title":"Carbon nanotubes enhance cytotoxicity mediated by human lymphocytes in vitro","volume":"6","author":"Sun","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.jmgm.2022.108280_bib25","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1038\/nbt875","article-title":"The potential environmental impact of engineered nanomaterials","volume":"21","author":"Colvin","year":"2003","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.jmgm.2022.108280_bib26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s12951-017-0259-4","article-title":"Multi-walled carbon nanotubes functionalized with recombinant Dengue virus 3 envelope proteins induce significant and specific immune responses in mice","volume":"15","author":"Versiani","year":"2017","journal-title":"J. Nanobiotechnol."},{"key":"10.1016\/j.jmgm.2022.108280_bib27","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.toxlet.2005.08.011","article-title":"Functionalization density dependence of single-walled carbon nanotubes cytotoxicity in vitro","volume":"161","author":"Sayes","year":"2006","journal-title":"Toxicol. Lett."},{"key":"10.1016\/j.jmgm.2022.108280_bib28","doi-asserted-by":"crossref","first-page":"3357","DOI":"10.1073\/pnas.0509009103","article-title":"Tissue biodistribution and blood clearance rates of intravenously administered carbon nanotube radiotracers","volume":"103","author":"Singh","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2022.108280_bib29","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1021\/ar700089b","article-title":"Functionalized carbon nanotubes in drug design and discovery","volume":"41","author":"Prato","year":"2008","journal-title":"Acc. Chem. Res."},{"key":"10.1016\/j.jmgm.2022.108280_bib30","doi-asserted-by":"crossref","first-page":"16968","DOI":"10.1073\/pnas.1105270108","article-title":"Binding of blood proteins to carbon nanotubes reduces cytotoxicity","volume":"108","author":"Ge","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jmgm.2022.108280_bib31","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jtice.2014.01.008","article-title":"HIV protease: multiple fold inhibition by silver nanoparticles-Spectrofluorimetric, thermodynamic and kinetic analysis","volume":"45","author":"Shing","year":"2014","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.jmgm.2022.108280_bib32","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jtice.2019.07.019","article-title":"Interactions between HIV-1 protease, silver nanoparticles, and specific peptides","volume":"103","author":"Tsai","year":"2019","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.jmgm.2022.108280_bib33","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.jtice.2015.10.029","article-title":"Docking of HIV protease to silver nanoparticles","volume":"60","author":"Whiteley","year":"2016","journal-title":"J. Taiwan Inst. Chem. Eng."},{"key":"10.1016\/j.jmgm.2022.108280_bib34","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1021\/acs.chemrestox.8b00141","article-title":"Adsorption of plasma proteins on single-walled carbon nanotubes reduced cytotoxicity and modulated neutrophil activation","volume":"31","author":"Lu","year":"2018","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.jmgm.2022.108280_bib35","series-title":"View 5.0, User's Reference. Pittsburgh","author":"Nielsen","year":"2009"},{"key":"10.1016\/j.jmgm.2022.108280_bib36","series-title":"Gaussian 09. Wallingford CT","author":"Frisch","year":"2009"},{"key":"10.1016\/j.jmgm.2022.108280_bib37","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1021\/j100142a004","article-title":"A well-behaved electrostatic potential based method using charge restraints for deriving atomic charges: the RESP model","volume":"97","author":"Bayly","year":"1993","journal-title":"J. Phys. Chem."},{"key":"10.1016\/j.jmgm.2022.108280_bib38","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/ja00299a024","article-title":"Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model","volume":"107","author":"Dewar","year":"1985","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2022.108280_bib39","doi-asserted-by":"crossref","first-page":"W363","DOI":"10.1093\/nar\/gki481","article-title":"PatchDock and SymmDock: servers for rigid and symmetric docking","volume":"33","author":"Schneidman-Duhovny","year":"2005","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.jmgm.2022.108280_bib40","doi-asserted-by":"crossref","first-page":"8454","DOI":"10.1021\/bi00098a024","article-title":"Human immunodeficiency virus-1 protease. 2. Use of pH rate studies and solvent kinetic isotope effects to elucidate details of chemical mechanism","volume":"30","author":"Hyland","year":"1991","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2022.108280_bib41","doi-asserted-by":"crossref","first-page":"9945","DOI":"10.1021\/bi961268z","article-title":"Solution NMR evidence that the HIV-1 protease catalytic aspartyl groups have different ionization states in the complex formed with the asymmetric drug KNI-272","volume":"35","author":"Wang","year":"1996","journal-title":"Biochemistry"},{"key":"10.1016\/j.jmgm.2022.108280_bib42","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/prot.21123","article-title":"Comparison of multiple Amber force fields and development of improved protein backbone parameters","volume":"65","author":"Hornak","year":"2006","journal-title":"Proteins"},{"key":"10.1016\/j.jmgm.2022.108280_bib43","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1063\/1.445869","article-title":"Comparison of simple potential functions for simulating liquid water","volume":"79","author":"Jorgensen","year":"1983","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2022.108280_bib44","doi-asserted-by":"crossref","first-page":"8577","DOI":"10.1063\/1.470117","article-title":"A smooth particle mesh Ewald method","volume":"103","author":"Essmann","year":"1995","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2022.108280_bib45","doi-asserted-by":"crossref","first-page":"3684","DOI":"10.1063\/1.448118","article-title":"Molecular dynamics with coupling to an external bath","volume":"81","author":"Berendsen","year":"1984","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2022.108280_bib46","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/0021-9991(77)90098-5","article-title":"Numerical integration of the cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes","volume":"23","author":"Ryckaert","year":"1977","journal-title":"J. Comput. Phys."},{"key":"10.1016\/j.jmgm.2022.108280_bib47","series-title":"AMBER 11","author":"Case","year":"2010"},{"key":"10.1016\/j.jmgm.2022.108280_bib48","doi-asserted-by":"crossref","first-page":"3712","DOI":"10.1021\/jp994072s","article-title":"Modification of the generalized Born model suitable for macromolecules","volume":"104","author":"Onufriev","year":"2000","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2022.108280_bib49","doi-asserted-by":"crossref","first-page":"7916","DOI":"10.1021\/ja981206r","article-title":"Flexibility and function in HIV protease: dynamics of the HIV-1 protease bound to the asymmetric inhibitor kynostatin 272 (KNI-272)","volume":"120","author":"Freedberg","year":"1998","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2022.108280_bib50","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1006\/jmbi.2001.5173","article-title":"Relation between sequence and structure of HIV-1 protease inhibitor complexes: a model system for the analysis of protein flexibility","volume":"315","author":"Zoete","year":"2002","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.jmgm.2022.108280_bib51","doi-asserted-by":"crossref","DOI":"10.1063\/1.3148022","article-title":"Coarse-grained molecular dynamics of ligands binding into protein: the case of HIV-1 protease inhibitors","volume":"130","author":"Li","year":"2009","journal-title":"J. Chem. Phys."},{"key":"10.1016\/j.jmgm.2022.108280_bib52","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1021\/jp2074804","article-title":"Interaction of I50V mutant and I50L\/A71V double mutant HIV-protease with inhibitor TMC114 (darunavir): molecular dynamics simulation and binding free energy studies","volume":"116","author":"Meher","year":"2012","journal-title":"J. Phys. Chem. B"},{"key":"10.1016\/j.jmgm.2022.108280_bib53","doi-asserted-by":"crossref","first-page":"12012","DOI":"10.1128\/JVI.78.21.12012-12021.2004","article-title":"Structural and thermodynamic basis for the binding of TMC114, a next-generation human immunodeficiency virus type 1 protease inhibitor","volume":"78","author":"King","year":"2004","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2022.108280_bib54","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1110\/ps.0206402","article-title":"Overcoming drug resistance in HIV-1 chemotherapy: the binding thermodynamics of Amprenavir and TMC-126 to wild-type and drug-resistant mutants of the HIV-1 protease","volume":"11","author":"Ohtaka","year":"2002","journal-title":"Protein Sci."},{"key":"10.1016\/j.jmgm.2022.108280_bib55","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1021\/ct301063k","article-title":"A comparative molecular dynamics, MM-PBSA and thermodynamic integration study of saquinavir complexes with wild-type HIV-1 PR and L10I, G48V, L63P, A71V, G73S, V82A and I84V single mutants","volume":"9","author":"Tzoupis","year":"2013","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2022.108280_bib56","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.1021\/ci4002102","article-title":"A contribution to the drug resistance mechanism of darunavir, amprenavir, indinavir, and saquinavir complexes with HIV-1 protease due to flap mutation I50V: a systematic MM-PBSA and thermodynamic integration study","volume":"53","author":"Leonis","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2022.108280_bib57","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1021\/jm050943c","article-title":"Effectiveness of nonpeptide clinical inhibitor TMC-114 on HIV-1 protease with highly drug resistant mutations D30N, I50V, and L90M","volume":"49","author":"Kovalevsky","year":"2006","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2022.108280_bib58","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1021\/jm9704098","article-title":"Viracept (nelfinavir mesylate, AG1343): a potent, orally bioavailable inhibitor of HIV-1 protease","volume":"40","author":"Kaldor","year":"1997","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.jmgm.2022.108280_bib59","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1002\/jcc.20139","article-title":"Constant pH molecular dynamics in generalized Born implicit solvent","volume":"25","author":"Mongan","year":"2004","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.jmgm.2022.108280_bib60","doi-asserted-by":"crossref","first-page":"5144","DOI":"10.1128\/JVI.02706-06","article-title":"Unique thermodynamic response of tipranavir to human immunodeficiency virus type 1 protease drug resistance mutations","volume":"81","author":"Muzammil","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.jmgm.2022.108280_bib61","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1021\/ci900012k","article-title":"Molecular dynamics and free energy studies on the wild-type and mutated HIV-1 protease complexed with four approved drugs: mechanism of binding and drug resistance","volume":"49","author":"Alcaro","year":"2009","journal-title":"J. Chem. Inf. Model."},{"key":"10.1016\/j.jmgm.2022.108280_bib62","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1021\/ja0779250","article-title":"Rapid and accurate prediction of binding free energies for saquinavir-bound HIV-1 proteases","volume":"130","author":"Stoica","year":"2008","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jmgm.2022.108280_bib63","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1021\/ct4007037","article-title":"Computing clinically relevant binding free energies of HIV-1 protease inhibitors","volume":"10","author":"Wright","year":"2014","journal-title":"J. Chem. Theor. Comput."},{"key":"10.1016\/j.jmgm.2022.108280_bib64","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.jmb.2004.02.052","article-title":"High resolution crystal structures of HIV-1 protease with a potent non-peptide inhibitor (UIC-94017) active against multi-drug-resistant clinical strains","volume":"338","author":"Tie","year":"2004","journal-title":"J. Mol. Biol."}],"container-title":["Journal of Molecular Graphics and Modelling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326322001590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1093326322001590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T21:10:37Z","timestamp":1761081037000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1093326322001590"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":64,"alternative-id":["S1093326322001590"],"URL":"https:\/\/doi.org\/10.1016\/j.jmgm.2022.108280","relation":{},"ISSN":["1093-3263"],"issn-type":[{"value":"1093-3263","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Functionalized carbon nanotubes as an alternative to traditional anti-HIV-1 protease inhibitors: An understanding towards Nano-medicine development through MD simulations","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular Graphics and Modelling","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jmgm.2022.108280","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108280"}}